Johnson & Johnson submits New Drug Application for TAR-200 to treat bladder cancer

Creo Medical Group plc launches robotic-guided lung ablation procedures in the UK

Phase I/II clinical trial of Ariceum Therapeutics' 225Ac-SSO110 gets US FDA approval

Taiho Oncology reveals oral decitabine and cedazuridine to be included in NIH precision medicine trials

Adaptive Biotechnologies and NeoGenomics partner to expand MRD monitoring for blood cancer

HUTCHMED receives full NMPA approval for ORPATHYS in China for MET exon 14 skipping NSCLC

Vascarta collaborates with City College of New York to improve efficacy and safety of chemotherapy

GRAIL announces patient-reported outcomes from PATHFINDER study of Galleri multi-cancer early detection blood test

bioAffinity Technologies declares successful beta launch of CyPath Lung in Texas

Elicera Therapeutics receives ODD for ELC-100

Sanofi receives approval for Sarclisa in China for relapsed or refractory multiple myeloma

Nuformix submits Orphan Drug Application for NXP002 in IPF

GSK to acquire IDRx for USD1.15bn to advance GIST treatment

Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan receives US Priority Review for EGFR-mutated NSCLC

Telix Pharmaceuticals signs asset purchase agreement with ImaginAb